ALA arovella therapeutics limited

News: ALA Arovella Therapeutics Enters Global, Exclusive License With Sparx Group

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Oct 12 (Reuters) - Arovella Therapeutics Ltd (ALA) :

    • ENTERED INTO A GLOBAL, EXCLUSIVE LICENSE WITH SPARX GROUP
    • LICENSE TO DEVELOP A WORLD-FIRST INKT CELL THERAPY TARGETING A VALIDATED TARGET
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.5¢
Change
0.015(18.8%)
Mkt cap ! $113.6M
Open High Low Value Volume
8.1¢ 9.5¢ 8.1¢ $182.2K 2.104M

Buyers (Bids)

No. Vol. Price($)
1 141934 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 100000 1
View Market Depth
Last trade - 16.10pm 16/09/2025 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.